Szingapúr -
angol -
HSA (Health Sciences Authority)
reminyl prolonged release capsule 8 mg
johnson & johnson international (singapore) pte ltd - galantamine hbr. 10.25 mg eqv galantamine base - capsule, coated, extended release - 8 mg - galantamine hbr. 10.25 mg eqv galantamine base 8 mg
Szingapúr -
angol -
HSA (Health Sciences Authority)
xofigo solution for injection 1100kbqml
bayer (south east asia) pte ltd - radium-223 chloride - injection, solution (radiopharmaceutical) - 1000 kbq/ml - radium-223 chloride 1100 kbq/ml
Szingapúr -
angol -
HSA (Health Sciences Authority)
integrilin iv bolus injection 2 mgml
msd pharma (singapore) pte. ltd. - eptifibatide - injection - 2 mg/ml - eptifibatide 2 mg/ml
Szingapúr -
angol -
HSA (Health Sciences Authority)
integrilin iv infusion 0.75 mgml
msd pharma (singapore) pte. ltd. - eptifibatide - injection - 0.75 mg/ml - eptifibatide 0.75 mg/ml
Szingapúr -
angol -
HSA (Health Sciences Authority)
stivarga tablet 40mg
bayer (south east asia) pte ltd - regorafenib monohydrate 41.49mg eqv regorafenib - tablet, film coated - 40.00mg - regorafenib monohydrate 41.49mg eqv regorafenib 40.00mg
Szingapúr -
angol -
HSA (Health Sciences Authority)
zelboraf tablet 240mg
roche singapore pte. ltd. - vemurafenib in hypromellose acetate succinate 800mg eqv to vemurafenib - tablet, film coated - 240mg - vemurafenib in hypromellose acetate succinate 800mg eqv to vemurafenib 240mg
Szingapúr -
angol -
HSA (Health Sciences Authority)
bridion solution for injection 100mgml
msd pharma (singapore) pte. ltd. - sugammadex sodium 108.8mg eqv sugammadex - injection, solution - 100mg - sugammadex sodium 108.8mg eqv sugammadex 100mg
Szingapúr -
angol -
HSA (Health Sciences Authority)
ilaris powder for solution for injection 150mgvial
novartis (singapore) pte ltd - canakinumab - powder, for solution - 150mg - canakinumab 150mg
Szingapúr -
angol -
HSA (Health Sciences Authority)
exelon patch 15 (13.3mg24hr)
novartis (singapore) pte ltd - rivastigmine (as base) - patch, extended release - 27.000 mg - rivastigmine (as base) 27.000 mg
Európai Unió -
angol -
EMA (European Medicines Agency)
truscient
zoetis belgium sa - dibotermin alfa - bone morphogenetic proteins - dogs - osteoinductive agent for use in the treatment of long-bone fractures as an adjunct to standard surgical care using open fracture reduction in dogs.